Saturday, 31 October 2026European Markets

WEBSTEP And WAVESTONE Have A High Dividend Yield And Return On Equity In The Technology Sector.

Loading stream...

(vianews) - webstep (wstep.ol) is among this list of stock assets with the highest dividend rate and return on equity on the technology sector.

financial asset price forward dividend yield return on equity
webstep (wstep.ol) kr22.00 7.73% 10.27%
wavestone (wave.pa) €58.00 0.92% 18.01%

several euronext companies pay out dividends to its shareholders. the dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. webstep (wstep.ol)

7.73% forward dividend yield and 10.27% return on equity

webstep asa, together with its subsidiaries, provides information technology (it) consultancy services to public and private businesses in norway and sweden. the company offers digitalization, cloud migration and integration, internet of things, machine learning, it security, robotics, and analytics. its services include consulting, digitalization, .net, java, open source, full stack, front and back end, user experience, integration, mobility, cloud apps, machine learning, business intelligence, big data, data warehousing, virtual robotics, devops, application service management, and data science services; and cloud computing, cloud services, integration, sensor technology, product and service development, beacons, enterprise user experience, web analysis, design team, amazon web, azure, prediction, ai, mobility predictive modelling, predictive modelling, hackathon, business analysis, and search engine optimization services. the company serves banking, finance and insurance, public administration, agriculture and food production, it and telecommunication, commerce, and transportation industries. the company was founded in 2000 and is headquartered in oslo, norway.

earnings per share

as for profitability, webstep has a trailing twelve months eps of kr1.42.

pe ratio

webstep has a trailing twelve months price to earnings ratio of 15.49. meaning, the purchaser of the share is investing kr15.49 for every norwegian krone of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 10.27%.

more news about webstep.

2. wavestone (wave.pa)

0.92% forward dividend yield and 18.01% return on equity

wavestone sa provides technology consulting services primarily in france and internationally. it offers consulting services in the areas of financial services, manufacturing, retail and consumer goods, luxury, energy and utilities, transport and services, and government and international institutions. the company was formerly known as solucom sa and changed its name to wavestone sa in july 2016. wavestone sa was incorporated in 1990 and is headquartered in paris, france.

earnings per share

as for profitability, wavestone has a trailing twelve months eps of €2.51.

pe ratio

wavestone has a trailing twelve months price to earnings ratio of 23.11. meaning, the purchaser of the share is investing €23.11 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 18.01%.

volatility

wavestone's last week, last month's, and last quarter's current intraday variation average was 1.59%, 1.17%, and 1.66%.

wavestone's highest amplitude of average volatility was 1.59% (last week), 1.92% (last month), and 1.66% (last quarter).

volume

today's last reported volume for wavestone is 12710 which is 42.31% above its average volume of 8931.

moving average

wavestone's value is way above its 50-day moving average of €49.31 and way higher than its 200-day moving average of €48.25.

more news about wavestone.

In this story · Knowledge Files

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Data Wave Builds Toward Ivonescimab PDUFA, While Micro-Cap Biotech Exits the Market
Late October 2026 is a dense catalyst window led by ESMO 2026. Daiichi Sankyo's DXd antibody-drug conjugate (ADC) programs (DESTINY-Lung04, DESTINY-Breast11, REJOICE-Ovarian01/02, TUXEDO-3), Guardant's 25 abstracts and the PACE-LUNG ctDNA trial all report there. These feed into the FDA's 14 November 2026 PDUFA date for ivonescimab. Large and mid-cap developers with late-stage data and commercial launches (ZEGFROVY, ANKTIVA, MIUDELLA, lorundrostat, duvakitug) are drawing capital and attention. Spago Nanomedical's board decision to seek a Nasdaq First North delisting (EGM 19 November, application 25 January 2027) shows the capital squeeze on early-stage, single-asset names (Tumorad is Phase I).
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,514 source documents archived
Query this data → isubstrate.com